138 results
8-K
EX-1.1
SLNO
Soleno Therapeutics Inc
7 May 24
Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering of Common Stock
5:28pm
care related fraud and abuse laws, including, without limitation, the U.S. Anti-Kickback Statute (42 U.S.C. Section 1320a-7b(b)), the U.S. civil … law (42 U.S.C. § 1320a-7a), the Stark Law (42 U.S.C. §1395nn), 18 U.S.C. Sections 286 and 287, the health care fraud criminal provisions under HIPAA
D
l6itj4 aatbq
4 Oct 23
$59.99 mm in equity / options / securities to be acquired, sold $59.99 mm, 14 investors
10:36am
8-K
EX-10.1
n653li3sqp3ljzro
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-1.1
mchd05q1e
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
424B5
4z3yzec24621e3i
29 Sep 23
Prospectus supplement for primary offering
4:51pm
424B5
xfm415n2j7iqqcktuk
27 Sep 23
Prospectus supplement for primary offering
5:26pm
8-K
EX-10.1
u7ro2h1vb8fcq8 ru
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm